The concomitant usage of oxycodone HCl with all cytochrome P450 3A4 inhibitors may possibly lead to an increase in oxycodone plasma concentrations, which could boost or extend adverse reactions and will trigger perhaps lethal respiratory depression. Furthermore, discontinuation of a concomitantly made use of cytochrome P450 3A4 inducer may result i